Background There are no specific generally accepted therapies for the coronavirus disease
2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild …

Objectives The aim of this study is to explore the effectiveness and safety of high dose
dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to SARS-Cov …

Objective To determine whether high-dose dexamethasone increases the number of
ventilator-free days (VFD) among patients with acute respiratory distress syndrome (ARDS) …

Importance Limited effective therapeutics are available to hospitalized patients with COVID-
19. Clinical trials and observational studies have shown varying effects of systemic …

ABSTRACT Background Coronavirus disease 2019 (COVID-19) is associated with diffuse
lung damage. Corticosteroids may modulate immune-mediated lung injury and reducing …

Objective: The infection caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) spreads worldwide and is considered a pandemic. The most common …

Background Dexamethasone 6 mg daily for 10 days is the recommended treatment for
patients with severe or critical coronavirus disease 2019 (COVID-19). The evidence on the …

Background: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage.
Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce …

Dexamethasone implementation for COVID-19 management represented a milestone but
data regarding its impact and safety have not been consistently reproduced. We aimed to …

Abstract Background Coronavirus disease 2019 (Covid-19) is associated with diffuse lung
damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby …